ClinicalTrials.gg
Sign In

Endometrial Hyperplasia clinical trials

The registry lists 110 studies for Endometrial Hyperplasia across more than 10 countries. 38 are recruiting or about to start. 63 of them are mainly about Endometrial Hyperplasia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.

Get an email when these change. Save the Endometrial Hyperplasia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
39
Recruiting
21
Not yet recruiting
17
Status unknown
17
Active, not recruiting
8
Withdrawn
6

Phase

Phase 2
41
Phase 3
19
Phase 4
4
Early Phase 1
2
Phase 1
1

Where

United States
29
China
22
Italy
9
Egypt
6
United Kingdom
5
Turkey
4

Who runs them

Xiaojun Chen (7) · Peking University People's Hospital (5) · Fudan University (4) · Imperial College London (3) · University of Campania Luigi Vanvitelli (3) · National Cancer Institute (NCI) (3) · Milton S. Hershey Medical Center (3) · Korean Gynecologic Oncology Group (2)

What is being tested here

Drugs under test in Endometrial Hyperplasia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Tirzepatide404
Megestrol Acetate2410
Megestrol2410
Letrozole233
Semaglutide203
Atorvastatin202
Metformin116
Levonorgestrel124
Medroxyprogesterone Acetate103
Medroxyprogesterone103

Drug classes tested here GLP-1 receptor agonists 5 open · Hormonal contraceptives 2 open · Aromatase inhibitors 2 open · Statins 2 open

Coming up

5phase 3 studies under way
4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Who these studies take

Of the 21 Endometrial Hyperplasia studies recruiting now, 9 (43%) set no upper age limit and 11 (52%) stop at 75 or younger. 7 (33%) take children under 18. 20 (95%) are for women only and 0 (0%) for men only; 3 (14%) take healthy volunteers.

Recruiting studies that take each age, of 21
AgeWomenMen
104 (19%)1 (5%)
1820 (95%)1 (5%)
3020 (95%)1 (5%)
4019 (90%)1 (5%)
5010 (48%)1 (5%)
6510 (48%)1 (5%)
7510 (48%)1 (5%)
859 (43%)1 (5%)

Across all 110 studies, recruiting or not: 45% stop at 75 or younger and 38% at 65; 15% take children; 98% are for women only and 0% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 110. Browse all 110 → or search them.